Adial Pharmaceuticals (ADIL) Goodwill & Intangibles (2017 - 2026)

Adial Pharmaceuticals has reported Goodwill & Intangibles for 10 years, with the latest figure at $2643.0 in Q1 2026.

• Quarterly Goodwill & Intangibles fell 17.59% year-over-year to $2643.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2643.0 (down 17.59% YoY) and the FY2025 annual result came in at $2784.0, down 16.85% from the prior year.
• Goodwill & Intangibles slipped to $2643.0 in Q1 2026 per ADIL's latest filing, from $2784.0 in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $253871.0 in Q1 2022 and troughed at $2643.0 in Q1 2026.
• A 5-year average of $76998.4 and a median of $3772.0 in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 85.54% in 2022, then tumbled 98.51% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $253448.0 in 2022, then tumbled by 98.46% to $3913.0 in 2023, then decreased by 14.44% to $3348.0 in 2024, then slipped by 16.85% to $2784.0 in 2025, then fell by 5.06% to $2643.0 in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $2643.0, $2784.0, and $2925.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.